Proleukin ( DrugBank: - )

3 diseases

2. 筋萎縮性側索硬化症

臨床試験数 : 624 / 薬物数 : 611 - (DrugBank : 160) / 標的遺伝子数 : 172 - 標的パスウェイ数 : 225

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-005347-14-GB (EUCTR)	25/08/2016	09/05/2016	Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for controlling neuro-inflammation ...	Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for controlling neuro-inflammation ...	Amyotrophic Lateral Sclerosis (ALS) MedDRA version: 20.0;Level: PT;Classification code 10002026;Term ...	Trade Name: Proleukin 18 MUI Product Name: proleukin	CHU DE NIMES	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	216	Phase 2	United Kingdom

臨床試験数 : 946 / 薬物数 : 722 - (DrugBank : 186) / 標的遺伝子数 : 117 - 標的パスウェイ数 : 199

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03312335 (ClinicalTrials.gov)	August 8, 2018	29/9/2017	Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus	Open-label, Monocentric, Phase II, Investigator-initiated Clinical Trial on Unbiased Characterizatio ...	Lupus Erythematosus, Systemic	Drug: Low-dose Aldesleukin (Proleukin®)	Onur Boyman, MD	NULL	Completed	18 Years	N/A	All	16	Phase 2	Switzerland
2	EUCTR2013-001599-40-DE (EUCTR)	03/01/2014	14/11/2013	Evaluation of the therapeutic potential of a low-dose therapy with the interleukin-2 analogue Aldesl ...	Evaluation of the safety, tolerability, efficacy and immunological responses of the interleukin-2 an ...	Patients with systemic lupus erythematosus (SLE) and increased disease activity refractory to standa ...	Trade Name: Proleukin Product Name: Proleukin INN or Proposed INN: Aldesleukin Other descriptive name: ...	Charité - Universitätsmedizin Berlin	NULL	Not Recruiting			Female: yes Male: yes	12	Phase 1;Phase 2	Germany

臨床試験数 : 482 / 薬物数 : 653 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 212

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2015-003369-27-DE (EUCTR)	01/07/2016	18/05/2016	A Phase I-IIa trial on low-dose IL-2 (Aldesleukin) treatment for immunological dysregulation in comm ...	A Phase I-IIa trial on low-dose IL-2 (Aldesleukin) treatment for immunological dysregulation in comm ...	autoimmune enteropathy (AIE) in common variable immunodeficiency (CVID). MedDRA version: 19.0;Level: ...	Trade Name: PROLEUKIN® S Product Name: Aldesleukin INN or Proposed INN: Aldesleukin Other descriptive n ...	Universitätsklinikum Freiburg	NULL	Not Recruiting			Female: yes Male: yes	6	Phase 2	Germany